{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_c5_inhibitors",
          "name": "C5 Inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_complement_inhibitors",
          "name": "Complement Inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_fostamatinib",
          "name": "Fostamatinib"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_luspatercept",
          "name": "Luspatercept"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_dexamethasone",
          "name": "Dexamethasone"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_cyclosporine",
          "name": "Cyclosporine"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_tacrolimus",
          "name": "Tacrolimus"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_sirolimus",
          "name": "Sirolimus"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_thrombopoietin_receptor_agonists",
          "name": "Thrombopoietin receptor agonists"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_c5_inhibitors",
          "type": "Drug",
          "label": "C5 Inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_complement_inhibitors",
          "type": "Drug",
          "label": "Complement Inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_fostamatinib",
          "type": "Drug",
          "label": "Fostamatinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_luspatercept",
          "type": "Drug",
          "label": "Luspatercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dexamethasone",
          "type": "Drug",
          "label": "Dexamethasone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thrombopoietin_receptor_agonists",
          "type": "Drug",
          "label": "Thrombopoietin receptor agonists",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_aHUS",
          "type": "Disease",
          "label": "Atypical Haemolytic Uraemic Syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_eculizumab",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "已知对aHUS的有效性"
        },
        {
          "source": "drug_ravulizumab",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "与Eculizumab相似的机制"
        },
        {
          "source": "drug_c5_inhibitors",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "同类药物作用于同一个靶点"
        },
        {
          "source": "drug_complement_inhibitors",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "补体途径相关性"
        },
        {
          "source": "drug_fostamatinib",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "治疗效果相关的文献"
        },
        {
          "source": "drug_luspatercept",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "新兴疗法潜力"
        },
        {
          "source": "drug_dexamethasone",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "免疫调节作用"
        },
        {
          "source": "drug_cyclosporine",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "临床用药背景"
        },
        {
          "source": "drug_tacrolimus",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "相关机制推测"
        },
        {
          "source": "drug_sirolimus",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "可考虑作为辅助疗法"
        },
        {
          "source": "drug_rituximab",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "针对免疫性异常的作用"
        },
        {
          "source": "drug_thrombopoietin_receptor_agonists",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "用于症状管理的潜力"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物对Atypical haemolytic uraemic syndrome显示出潜在作用",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "各药物具备足够达到靶组织的生物利用度"
    ],
    "uncertainties": [
      "长期疗效和安全性未知，需进一步研究"
    ],
    "next_focus_for_pi": [
      "评估各药物的临床试验数据以确认疗效"
    ]
  }
}